デフォルト表紙
市場調査レポート
商品コード
1709995

成体幹細胞アッセイの世界市場レポート 2025年

Adult Stem Cell Assay Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
成体幹細胞アッセイの世界市場レポート 2025年
出版日: 2025年04月03日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

成体幹細胞アッセイの市場規模は今後数年で急成長が見込まれます。2029年には年間平均成長率(CAGR)15.8%で214億3,000万米ドルに成長します。予測期間の成長は、高齢化人口の増加、個別化医療への高まり、投資とインフラの拡大、再生医療への需要の高まり、研究関連活動への支出の増加などに起因しています。予測期間における主な動向としては、人工知能と自動化の統合、臓器オンチップ技術の採用、組織工学の開発、創薬開発、臨床研究などが挙げられます。

再生医療に対する需要の高まりは、成体幹細胞アッセイ市場の成長を牽引すると予想されます。再生医療は、加齢、疾患、外傷、先天性疾患によって損傷を受けた細胞、組織、臓器の正常な機能の置換、修復、回復を目的とした生物医学的技術を含みます。世界人口の高齢化は、再生医療、特に関節炎や心血管疾患などの加齢に関連した疾患に対処する治療に対する需要を煽っています。成体幹細胞アッセイは、細胞の分化、増殖、遊走、相互作用などを評価するために不可欠であり、幹細胞治療を含む再生医療における細胞の生存能力や有効性を評価するために極めて重要です。例えば、2023年7月に発表された米国遺伝子・細胞治療学会(ASGCT)とCiteline社による報告書によると、第Ⅱ相段階にある遺伝子治療薬の数は、2023年第1四半期末の247件から5%増加し、第2四半期末には260件となりました。こうした再生医療への注目の高まりが、成体幹細胞アッセイ市場を後押ししています。

成体幹細胞アッセイ市場の主要企業は、治療結果の予測可能性を高め、個別化治療の開発を加速するために、すぐに使用できる先進的な器官管アッセイモデルを開発しています。これらの組み立て済みシステムは、成体幹細胞由来のオルガノイドを利用し、すぐに研究に応用できるように設計されています。例えば、2023年3月、臓器オンチップベースの疾患モデルを提供するオランダのMIMETAS社は、OrganoReady製品ラインを発表しました。この製品には、完全に調製された成体幹細胞(ASC)由来の器官管ベースのアッセイモデルが含まれ、細胞培養と組織作製を簡素化し、迅速な実験を容易にします。OrganoReadyモデルは、ASC由来の結腸および腎臓オルガノイド細管を備えており、機序毒性学および薬剤誘発性臓器傷害研究用に最適化されています。プレートあたり64個のオルガノイドを備え、ミディアムからハイスループットのスクリーニングをサポートし、成体幹細胞アッセイ用の強固なプラットフォームを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界成体幹細胞アッセイ PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の成体幹細胞アッセイ市場:成長率分析
  • 世界の成体幹細胞アッセイ市場の実績:規模と成長, 2019-2024
  • 世界の成体幹細胞アッセイ市場の予測:規模と成長, 2024-2029, 2034F
  • 世界成体幹細胞アッセイ総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の成体幹細胞アッセイ市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 生存率または細胞毒性
  • 分離と精製
  • 細胞識別
  • 増殖
  • 差別化
  • 関数
  • アポトーシス
  • 世界の成体幹細胞アッセイ市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 再生医療と治療法の開発
  • 医薬品の発見と開発
  • 臨床調査
  • 世界の成体幹細胞アッセイ市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 政府調査機関
  • 民間調査機関
  • 業界調査
  • 世界の成体幹細胞アッセイ市場生存能または細胞毒性のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 細胞生存率アッセイ
  • 細胞毒性アッセイ
  • 生細胞または死細胞染色アッセイ
  • 世界の成体幹細胞アッセイ市場、分離と精製のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 磁気活性化細胞選別(MACS)
  • 蛍光活性化細胞選別法(FACS)
  • 密度勾配遠心分離
  • 酵素消化法
  • 世界の成体幹細胞アッセイ市場、細胞識別のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 表面マーカー分析
  • 免疫細胞化学
  • 遺伝子発現プロファイリング
  • 世界の成体幹細胞アッセイ市場、増殖のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 細胞増殖アッセイ
  • CFSE希釈アッセイ
  • コロニー形成単位(CFU)アッセイ
  • 世界の成体幹細胞アッセイ市場、タイプ別差別化のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 系統追跡アッセイ
  • 分化マーカー分析
  • 多能性分化アッセイ
  • 世界の成体幹細胞アッセイ市場、機能のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 機能アッセイ
  • インビトロ機能アッセイ
  • 代謝活性アッセイ
  • 世界の成体幹細胞アッセイ市場アポトーシスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • カスパーゼ活性アッセイ
  • TUNELアッセイ(末端デオキシヌクレオチド転移酵素dUTPニック末端標識)
  • アネキシンV/ヨウ化プロピジウム染色

第7章 地域別・国別分析

  • 世界の成体幹細胞アッセイ市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の成体幹細胞アッセイ市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 成体幹細胞アッセイ市場:競合情勢
  • 成体幹細胞アッセイ市場:企業プロファイル
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
    • Sigma Aldrich Chemicals Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • STEMCELL Technologies Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Promega Corporation
  • Abcam Plc
  • R&D Systems Inc.
  • BioLegend Inc.
  • Sino Biological Inc.
  • Cell Signaling Technology, Inc.
  • Enzo Biochem Inc.
  • Creative Bioarray
  • ScienCell Research Laboratories Inc.
  • Cell Biolabs Inc.
  • Abnova Corporation
  • American Type Culture Collection
  • AMSBIO LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 成体幹細胞アッセイ市場2029:新たな機会を提供する国
  • 成体幹細胞アッセイ市場2029:新たな機会を提供するセグメント
  • 成体幹細胞アッセイ市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r31573

An adult stem cell assay is a laboratory test used to analyze the behavior and characteristics of adult stem cells, which are undifferentiated cells with the ability to self-renew and differentiate into specific tissue types. The primary aim of the assay is to evaluate the stem cells' capacity to regenerate tissues, their potential for differentiation, and their therapeutic efficacy in treating diseases.

The main types of adult stem cell assays include viability or cytotoxicity, isolation and purification, cell identification, proliferation, differentiation, function, and apoptosis. The viability or cytotoxicity assay assesses the health of stem cells by measuring cell survival and their responses to various conditions to determine the effects of potential toxins. These assays are utilized in regenerative medicine, therapy development, drug discovery, and clinical research, serving various end-users such as government research institutes, private research organizations, and industry research facilities.

The adult stem cell assays market research report is one of a series of new reports from The Business Research Company that provides adult stem cell assays market statistics, including the adult stem cell assays industry global market size, regional shares, competitors with the adult stem cell assays market share, detailed adult stem cell assays market segments, market trends, and opportunities, and any further data you may need to thrive in the adult stem cell assays industry. These adult stem cell assays market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The adult stem cell assay market size has grown rapidly in recent years. It will grow from $10.28 $ billion in 2024 to $11.93 $ billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to rise of regenerative medicine, increasing amount of research interest, growing applications in medicine, rising prevalence of chronic diseases, and rise in approvals of clinical trials.

The adult stem cell assay market size is expected to see rapid growth in the next few years. It will grow to $21.43 $ billion in 2029 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to increase in the aging population, the growing push towards personalized medicine, growing investments and infrastructure, growing demand for regenerative medicine, and rising expenditure in research-related activities. Major trends in the forecast period include the integration of artificial intelligence and automation, the adoption of organ-on-a-chip technologies, developments in tissue engineering, drug discovery and development, and clinical research.

The increasing demand for regenerative medicine is expected to drive the growth of the adult stem cell assay market. Regenerative medicine involves biomedical techniques aimed at replacing, repairing, or restoring the normal function of cells, tissues, or organs that have been damaged by aging, disease, trauma, or congenital conditions. The aging global population is fueling the demand for regenerative medicine, particularly for treatments addressing age-related diseases such as arthritis and cardiovascular conditions. Adult stem cell assays are essential for assessing cell differentiation, proliferation, migration, and interactions, which are crucial for evaluating cell viability and effectiveness in regenerative medicine, including stem cell therapies. For example, a report by the American Society of Gene & Cell Therapy (ASGCT) and Citeline published in July 2023 indicated that the number of gene therapies in Phase II increased by 5% from 247 at the end of Q1 2023 to 260 by the end of Q2. This growing focus on regenerative medicine is propelling the adult stem cell assay market.

Leading companies in the adult stem cell assay market are developing advanced, ready-to-use organoid tubule assay models to enhance the predictability of therapeutic outcomes and accelerate the development of personalized treatments. These pre-assembled systems utilize organoids derived from adult stem cells and are designed for immediate research application. For instance, in March 2023, MIMETAS, a Netherlands-based provider of organ-on-a-chip-based disease models, introduced the OrganoReady product line. This product includes a fully prepared adult stem cell (ASC)-derived organoid tubule-based assay model, which simplifies cell culture and tissue creation, facilitating rapid experimentation. The OrganoReady model features ASC-derived colon and kidney organoid tubules, optimized for mechanistic toxicology and drug-induced organ injury studies. With 64 organoids per plate, it supports medium- to high-throughput screening, offering a robust platform for adult stem cell assays.

In January 2024, STEMCELL Technologies Inc., a biotechnology firm based in Canada, purchased Propagenix Inc. for an undisclosed sum. This acquisition is intended to strengthen STEMCELL Technologies' presence in the adult stem cell assay market by incorporating Propagenix's technologies and expertise, which will improve the creation of innovative research tools and solutions. Propagenix Inc. is a biotechnology company located in the United States.

Major companies operating in the adult stem cell assay market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Lonza Group AG, Sartorius AG, Sigma Aldrich Chemicals Pvt. Ltd., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Abcam Plc, R&D Systems Inc., BioLegend Inc., Sino Biological Inc., Cell Signaling Technology, Inc., Enzo Biochem Inc., Creative Bioarray, ScienCell Research Laboratories Inc., Cell Biolabs Inc., Abnova Corporation, American Type Culture Collection, AMSBIO LLC

North America was the largest region in the adult stem cell assay market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult stem cell assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adult stem cell assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The adult stem cell assay market consists of revenues earned by entities by providing services such as colony-forming unit (CFU) assays, migration and invasion assays, toxicity screening, multipotency assays, gene editing, and genetic manipulation. The market value includes the value of related goods sold by the service provider or included within the service offering. The adult stem cell assay market also includes sales of incubators, centrifuges, microscopes, plate readers, and PCR machines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adult Stem Cell Assay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adult stem cell assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adult stem cell assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adult stem cell assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Viability Or Cytotoxicity; Isolation And Purification; Cell Identification; Proliferation; Differentiation; Function; Apoptosis
  • 2) By Application: Regenerative Medicine And Therapy Development; Drug Discovery And Development; Clinical Research
  • 3) By End-User: Government Research Institutes; Private Research Institutes; Industry Research
  • Subsegments:
  • 1) By Viability or Cytotoxicity: Cell Viability Assays; Cytotoxicity Assays; Live Or Dead Cell Staining Assays
  • 2) By Isolation and Purification: Magnetic-Activated Cell Sorting (MACS); Fluorescence-Activated Cell Sorting (FACS); Density Gradient Centrifugation; Enzymatic Digestion Methods
  • 3) By Cell Identification: Surface Marker Analysis; Immunocytochemistry; Gene Expression Profiling
  • 4) By Proliferation: Cell Proliferation Assays; CFSE Dilution Assays; Colony-Forming Unit (CFU) Assays
  • 5) By Differentiation: Lineage Tracing Assays; Differentiation Marker Analysis; Multipotent Differentiation Assays
  • 6) By Function: Functional Assays; In Vitro Functional Assays; Metabolic Activity Assays
  • 7) By Apoptosis: Caspase Activity Assays; TUNEL Assay (Terminal deoxynucleotidyl transferase dUTP nick end labeling); Annexin V/Propidium Iodide Staining
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Becton, Dickinson and Company; Lonza Group AG; Sartorius AG; Sigma Aldrich Chemicals Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Adult Stem Cell Assay Market Characteristics

3. Adult Stem Cell Assay Market Trends And Strategies

4. Adult Stem Cell Assay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Adult Stem Cell Assay Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Adult Stem Cell Assay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Adult Stem Cell Assay Market Growth Rate Analysis
  • 5.4. Global Adult Stem Cell Assay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Adult Stem Cell Assay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Adult Stem Cell Assay Total Addressable Market (TAM)

6. Adult Stem Cell Assay Market Segmentation

  • 6.1. Global Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Viability Or Cytotoxicity
  • Isolation And Purification
  • Cell Identification
  • Proliferation
  • Differentiation
  • Function
  • Apoptosis
  • 6.2. Global Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Regenerative Medicine And Therapy Development
  • Drug Discovery And Development
  • Clinical Research
  • 6.3. Global Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Government Research Institutes
  • Private Research Institutes
  • Industry Research
  • 6.4. Global Adult Stem Cell Assay Market, Sub-Segmentation Of Viability or Cytotoxicity, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Viability Assays
  • Cytotoxicity Assays
  • Live Or Dead Cell Staining Assays
  • 6.5. Global Adult Stem Cell Assay Market, Sub-Segmentation Of Isolation and Purification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Magnetic-Activated Cell Sorting (MACS)
  • Fluorescence-Activated Cell Sorting (FACS)
  • Density Gradient Centrifugation
  • Enzymatic Digestion Methods
  • 6.6. Global Adult Stem Cell Assay Market, Sub-Segmentation Of Cell Identification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surface Marker Analysis
  • Immunocytochemistry
  • Gene Expression Profiling
  • 6.7. Global Adult Stem Cell Assay Market, Sub-Segmentation Of Proliferation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Proliferation Assays
  • CFSE Dilution Assays
  • Colony-Forming Unit (CFU) Assays
  • 6.8. Global Adult Stem Cell Assay Market, Sub-Segmentation Of Differentiation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lineage Tracing Assays
  • Differentiation Marker Analysis
  • Multipotent Differentiation Assays
  • 6.9. Global Adult Stem Cell Assay Market, Sub-Segmentation Of Function, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Functional Assays
  • In Vitro Functional Assays
  • Metabolic Activity Assays
  • 6.10. Global Adult Stem Cell Assay Market, Sub-Segmentation Of Apoptosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Caspase Activity Assays
  • TUNEL Assay (Terminal deoxynucleotidyl transferase dUTP nick end labeling)
  • Annexin V/Propidium Iodide Staining

7. Adult Stem Cell Assay Market Regional And Country Analysis

  • 7.1. Global Adult Stem Cell Assay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Adult Stem Cell Assay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Adult Stem Cell Assay Market

  • 8.1. Asia-Pacific Adult Stem Cell Assay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Adult Stem Cell Assay Market

  • 9.1. China Adult Stem Cell Assay Market Overview
  • 9.2. China Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Adult Stem Cell Assay Market

  • 10.1. India Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Adult Stem Cell Assay Market

  • 11.1. Japan Adult Stem Cell Assay Market Overview
  • 11.2. Japan Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Adult Stem Cell Assay Market

  • 12.1. Australia Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Adult Stem Cell Assay Market

  • 13.1. Indonesia Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Adult Stem Cell Assay Market

  • 14.1. South Korea Adult Stem Cell Assay Market Overview
  • 14.2. South Korea Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Adult Stem Cell Assay Market

  • 15.1. Western Europe Adult Stem Cell Assay Market Overview
  • 15.2. Western Europe Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Adult Stem Cell Assay Market

  • 16.1. UK Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Adult Stem Cell Assay Market

  • 17.1. Germany Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Adult Stem Cell Assay Market

  • 18.1. France Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Adult Stem Cell Assay Market

  • 19.1. Italy Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Adult Stem Cell Assay Market

  • 20.1. Spain Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adult Stem Cell Assay Market

  • 21.1. Eastern Europe Adult Stem Cell Assay Market Overview
  • 21.2. Eastern Europe Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Adult Stem Cell Assay Market

  • 22.1. Russia Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Adult Stem Cell Assay Market

  • 23.1. North America Adult Stem Cell Assay Market Overview
  • 23.2. North America Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Adult Stem Cell Assay Market

  • 24.1. USA Adult Stem Cell Assay Market Overview
  • 24.2. USA Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Adult Stem Cell Assay Market

  • 25.1. Canada Adult Stem Cell Assay Market Overview
  • 25.2. Canada Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Adult Stem Cell Assay Market

  • 26.1. South America Adult Stem Cell Assay Market Overview
  • 26.2. South America Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Adult Stem Cell Assay Market

  • 27.1. Brazil Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Adult Stem Cell Assay Market

  • 28.1. Middle East Adult Stem Cell Assay Market Overview
  • 28.2. Middle East Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Adult Stem Cell Assay Market

  • 29.1. Africa Adult Stem Cell Assay Market Overview
  • 29.2. Africa Adult Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Adult Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Adult Stem Cell Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Adult Stem Cell Assay Market Competitive Landscape And Company Profiles

  • 30.1. Adult Stem Cell Assay Market Competitive Landscape
  • 30.2. Adult Stem Cell Assay Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sigma Aldrich Chemicals Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Adult Stem Cell Assay Market Other Major And Innovative Companies

  • 31.1. STEMCELL Technologies Inc.
  • 31.2. Miltenyi Biotec B.V. & Co. KG
  • 31.3. Promega Corporation
  • 31.4. Abcam Plc
  • 31.5. R&D Systems Inc.
  • 31.6. BioLegend Inc.
  • 31.7. Sino Biological Inc.
  • 31.8. Cell Signaling Technology, Inc.
  • 31.9. Enzo Biochem Inc.
  • 31.10. Creative Bioarray
  • 31.11. ScienCell Research Laboratories Inc.
  • 31.12. Cell Biolabs Inc.
  • 31.13. Abnova Corporation
  • 31.14. American Type Culture Collection
  • 31.15. AMSBIO LLC

32. Global Adult Stem Cell Assay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adult Stem Cell Assay Market

34. Recent Developments In The Adult Stem Cell Assay Market

35. Adult Stem Cell Assay Market High Potential Countries, Segments and Strategies

  • 35.1 Adult Stem Cell Assay Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Adult Stem Cell Assay Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Adult Stem Cell Assay Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer